SCHEMBL7446281

SCHEMBL7446281

CCCC[C@H](NC(=O)[C@H](Cc1ccccc1)N(C)S(=O)(=O)c1ccc(OC)c(OC)c1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 1/20 0.45
ADAMTS5 Q9UNA0 1/20 0.43
ITGB3 P05106 1/20 0.43
ITGAV P06756 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43
HCRTR1 O43613 1/20 0.43
HCRTR2 O43614 1/20 0.43
TP53 P04637 1/20 0.43
PDE4A P27815 5/20 0.42
PDE4B Q07343 5/20 0.42
PDE4C Q08493 5/20 0.42
PDE4D Q08499 5/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TAS2R14 Q9NYV8 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ALOX15 P16050 1/20 0.41
MME P08473 1/20 0.41
ACE P12821 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7447599 0.85 CA2 (0.44) ITGB3ITGAVCA12CA1CA9
SCHEMBL7451514 0.83 ITGB3 (0.55) FPR2ITGB3ITGAVALDH1A1ALOX15
SCHEMBL7448467 0.78 PDE4A (0.49) ITGB3ITGAVPDE4APDE4BPDE4C
SCHEMBL7444233 0.78 ITGB3 (0.47) ITGB3ITGAVCA12CA9HCRTR1
SCHEMBL7445397 0.77 KMT2A (0.52) ITGB3ITGAVPDE4APDE4BPDE4C
SCHEMBL5572404 0.74 ADAMTS5 (0.56) ADAMTS5CA12CA1CA9ALDH1A1
SCHEMBL5572403 0.74 ADAMTS5 (0.56) ADAMTS5CA12CA1CA9ALDH1A1
SCHEMBL7445017 0.74 ITGB3 (0.48) ITGB3ITGAVPDE4APDE4BPDE4C
SCHEMBL7448898 0.74 ITGB3 (0.47) ITGB3ITGAVPDE4APDE4BPDE4C
SCHEMBL7449150 0.73 ITGB3 (0.46) ITGB3ITGAVPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6221888-B1 ANTIHISTAMINE, ANTIINFLAMMATORY AGENT, AUTOIMMUNE DISEASE, RHEUMATIC DISORDERS MERCK & CO., INC. 2001-04-24 US claimed
EP-0998282-A4 SULFONAMIDES AS CELL ADHESION INHIBITORS MERCK & CO INC (US) 2000-08-30 EP claimed
EP-0998282-A1 SULFONAMIDES AS CELL ADHESION INHIBITORS Merck & Co., Inc. (a New Jersey corp.) (US) 2000-05-10 EP claimed
WO-1998053818-A1 SULFONAMIDES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 1998-12-03 WO claimed